UiPath Vs. ServiceNow: Which Agentic AI Stock Is the Better Buy?

The market is likely underpricing how much of this “agentic AI” spend will be captured by workflow incumbents versus point solutions. NOW should keep winning the largest deals because it sits inside enterprise operating systems and can bundle agents into broader contract renewals; that makes it more resilient than a pure-play automation vendor if buyers consolidate vendors over the next 1-3 quarters. PATH can still rally on the back of margin inflection, but its upside is more sensitive to proof that agent adoption converts into durable net expansion rather than one-off productivity pilots.

Second-order effect: if procurement teams treat agents as a budget-reallocation exercise rather than incremental spend, the real losers may be smaller automation names and service integrators that resell labor-saving software. Over 6-18 months, the key question is whether agentic AI becomes a feature embedded in MSFT/CRM-style suites, which would compress standalone multiples, or a category that justifies premium verticalization; that’s the main falsifier for both stocks.

The consensus seems to overstate how quickly profitability can re-rate PATH and understate how hard it is for NOW to accelerate net income from already-high scale. The cleanest read is that PATH has more valuation torque if margins keep improving, while NOW has the better moat but less multiple expansion left unless it reaccelerates earnings growth. Watch the next two quarters for dollar-based retention, deal size, and whether AI attach rates move from narrative to measurable ARR; if not, this stays a trading setup, not a durable rerating.